Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros

Bases de datos
Tipo del documento
Intervalo de año de publicación
1.
Adv Clin Exp Med ; 28(12): 1609-1614, 2019 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-31851788

RESUMEN

BACKGROUND: During cerebral ischemia, energy restoration through the regulation of glucose transporters and antioxidant defense mechanisms is essential to maintain cell viability. Antioxidant therapy has been considered effective to attenuate brain damage; moreover, the regulation of transcription factors that positively regulate the expression of glucose transporters is associated with this therapy. Recently, it has been reported that the use of antioxidants such as S-allylcysteine (SAC), a component of aged garlic extract (AGE), improves survival in experimental models of cerebral ischemia. OBJECTIVES: The aim of this study was to determine the effect of AGE and SAC on the level of mRNA expression of the main neuronal glucose transporter (GLUT3) and the glutamate cysteine ligase catalytic subunit (GCLC) in rats with transient focal cerebral ischemia. MATERIAL AND METHODS: Cerebral ischemia was induced in male Wistar rats by middle cerebral artery occlusion (MCAO) for 2 h. The animals were sacrificed after different reperfusion times (0-48 h). Animals injected with AGE (360 mg/kg, intraperitoneally (i.p.)) and SAC (300 mg/kg, i.p.) at the beginning of reperfusion were sacrificed after 2 h. The mRNA expression level was analyzed in the fronto-parietal cortex using quantitative polymerase chain reaction (qPCR). RESULTS: Two major increases in GLUT3 expression at 1 h and 24 h of reperfusion were found. Both treatments increased GLUT3 and GCLC mRNA levels in control and under ischemic/reperfusion injury animals. CONCLUSIONS: This data suggests that SAC and AGE might induce neuroprotection, while controlling reactive oxygen species (ROS) levels, as indicated by the increase in GCLC expression, and regulating the energy content of the cell by increasing glucose transport mediated by GLUT3.


Asunto(s)
Isquemia Encefálica , Ajo , Proteínas Facilitadoras del Transporte de la Glucosa/metabolismo , Glutamato-Cisteína Ligasa/metabolismo , Fármacos Neuroprotectores , Animales , Antioxidantes/metabolismo , Antioxidantes/farmacología , Isquemia Encefálica/metabolismo , Cisteína/análogos & derivados , Cisteína/farmacología , Ajo/química , Proteínas Facilitadoras del Transporte de la Glucosa/efectos de los fármacos , Glutamato-Cisteína Ligasa/efectos de los fármacos , Masculino , Fármacos Neuroprotectores/uso terapéutico , Extractos Vegetales/farmacología , Ratas , Ratas Wistar , Daño por Reperfusión/metabolismo
2.
Int J Pediatr Otorhinolaryngol ; 92: 61-66, 2017 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-28012535

RESUMEN

OBJECTIVE: Cisplatin is commonly used to treat solid tumors. However, permanent hearing loss is a major side effect of cisplatin chemotherapy and often results in dose reduction of the cisplatin chemotherapy. Peanut sprouts show cytoprotective properties owing to their antioxidant activities. This study was designed to investigate the effect of peanut sprout extract (PSE) on cisplatin-induced ototoxicity in an auditory cell line, HEI-OC1 cells. METHODS: Cells were exposed to cisplatin for 24 h, with or without pre-treatment with PSE, cell viability was examined using the MTT assay. Apoptotic cells were identified by double staining with Hoechst 33258 and propidium iodide. Western blot analysis was performed to examine apoptotic proteins including C-PARP and C-caspase, anti-apoptotic protein Bcl-2, and Nrf2 redox system activation. Mitochondrial reactive oxygen species (ROS) were investigated to examine whether PSE could scavenge cisplatin-induced ROS. Real-time PCR analyses were performed to investigate the mRNA levels of antioxidant enzymes including NQO1, HO-1, GPx2, Gclc, and catalase. RESULTS: The cisplatin-treated group showed reduced cell viability, increased apoptotic properties and markers, and increased ROS levels. PSE pre-treatment before cisplatin exposure significantly increased cell viability and reduced apoptotic properties and ROS production. These effects resulted from the up-regulation of antioxidant genes, including NQO1, HO-1, GPx2, Gclc, and catalase through Akt phosphorylation and Nrf2 activation. CONCLUSION: Our results demonstrate that PSE protects from cisplatin-induced cytotoxicity by activating the antioxidant effects via the Akt/Nrf-2 pathway in this auditory cell line, and indicate that PSE may provide novel treatment to prevent cisplatin-induced ototoxicity.


Asunto(s)
Antineoplásicos/toxicidad , Apoptosis/efectos de los fármacos , Arachis , Cisplatino/toxicidad , Células Ciliadas Auditivas/efectos de los fármacos , Células Laberínticas de Soporte/efectos de los fármacos , Extractos Vegetales/farmacología , Plantones , Animales , Western Blotting , Caspasas/efectos de los fármacos , Caspasas/metabolismo , Catalasa/efectos de los fármacos , Catalasa/genética , Línea Celular , Supervivencia Celular/efectos de los fármacos , Glutamato-Cisteína Ligasa/efectos de los fármacos , Glutamato-Cisteína Ligasa/genética , Glutatión Peroxidasa/efectos de los fármacos , Glutatión Peroxidasa/genética , Hemo-Oxigenasa 1/efectos de los fármacos , Hemo-Oxigenasa 1/genética , Técnicas In Vitro , Proteínas de la Membrana/efectos de los fármacos , Proteínas de la Membrana/genética , Ratones , Mitocondrias/efectos de los fármacos , Mitocondrias/metabolismo , NAD(P)H Deshidrogenasa (Quinona)/efectos de los fármacos , NAD(P)H Deshidrogenasa (Quinona)/genética , Factor 2 Relacionado con NF-E2/efectos de los fármacos , Factor 2 Relacionado con NF-E2/metabolismo , Oxidación-Reducción/efectos de los fármacos , Poli(ADP-Ribosa) Polimerasas/efectos de los fármacos , Poli(ADP-Ribosa) Polimerasas/metabolismo , Proteínas Proto-Oncogénicas c-bcl-2/efectos de los fármacos , Proteínas Proto-Oncogénicas c-bcl-2/metabolismo , Especies Reactivas de Oxígeno/metabolismo , Reacción en Cadena en Tiempo Real de la Polimerasa , Regulación hacia Arriba
3.
J Med Assoc Thai ; 97 Suppl 8: S57-63, 2014 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-25518294

RESUMEN

BACKGROUND: Cymbopogon citratus, Stapf(CCS) is commonly known as lemon grass. Previous studies showed that it has a strong antioxidant property and have been traditionally used as analgesic, antipyretic, antiseptic in SoutheastAsia. However, the effect of CCS on antioxidant defense system has not been demonstrated. OBJECTIVE: The present study was conducted to investigate the effects of CCS water extract on rat antioxidant defense system, especially on the expression of y-glutamylcysteine ligase (γ-GCL) and heme oxygenase-1 (HO-1). MATERIAL AND METHOD: The CCS water extract was screenedfor its phytochemical contents and antioxidant activity in vitro. Moreover, the extract was studied in rats to evaluate its effects in vivo. Male Sprague-Dawley rats aged eight weeks (250±20 g) were orally administered with CCS at 250, 500 and 1,000 mg/kg/day for one month. RESULTS: The extract contained flavonoids (496.17 mg gallic acid/g CCS extract) and phenolic compounds (4,020.18 mg catechin/g CCS extract). The scavenging activity (DPPH assay) of the extract was demonstrated by EC50 of 917.76±86.89 µg/ ml whereas the EC50 of the potent antioxidant, vitamin C was 31.22±1.84 µg/ml. In the animals, the protein expression of antioxidant enzymes, γGCL and HO-1 was significantly increased in the high dose-treated animals (1,000 mg/kg/day). This was consistent with elevation ofserum total antioxidant capacity. CONCLUSION: Taken together the present study provides evidence that CCS water extract exhibits antioxidant activity and antioxidant enzymes induction in vivo.


Asunto(s)
Antioxidantes/farmacología , Cymbopogon , Glutamato-Cisteína Ligasa/efectos de los fármacos , Hemo-Oxigenasa 1/efectos de los fármacos , Extractos Vegetales/farmacología , Animales , Ácido Ascórbico/farmacología , Flavonoides/farmacología , Glutamato-Cisteína Ligasa/metabolismo , Hemo-Oxigenasa 1/metabolismo , Masculino , Fenoles/farmacología , Ratas , Ratas Sprague-Dawley
4.
Toxicol Appl Pharmacol ; 229(1): 44-55, 2008 May 15.
Artículo en Inglés | MEDLINE | ID: mdl-18299140

RESUMEN

Due to its unique physicochemical and optical properties, C60 has raised interest in commercialization for a variety of products. While several reports have determined this nanomaterial to act as a powerful antioxidant, many other studies have demonstrated a strong oxidative potential through photoactivation. To directly address the oxidative potential of C60, the effects of light and chemical supplementation and depletion of glutathione (GSH) on C60-induced toxicity were evaluated. Embryonic zebrafish were used as a model organism to examine the potential of C60 to elicit oxidative stress responses. Reduced light during C60 exposure significantly decreased mortality and the incidence of fin malformations and pericardial edema at 200 and 300 ppb C60. Embryos co-exposed to the glutathione precursor, N-acetylcysteine (NAC), also showed reduced mortality and pericardial edema; however, fin malformations were not reduced. Conversely, co-exposure to the GSH synthesis inhibitors, buthionine sulfoximine (BSO) and diethyl maleate (DEM), increased the sensitivity of zebrafish to C60 exposure. Co-exposure of C60 or its hydroxylated derivative, C60(OH)(24), with H2O2 resulted in increased mortality along the concentration gradient of H2O2 for both materials. Microarrays were used to examine the effects of C60 on the global gene expression at two time points, 36 and 48 h post fertilization (hpf). At both life stages there were alterations in the expression of several key stress response genes including glutathione-S-transferase, glutamate cysteine ligase, ferritin, alpha-tocopherol transport protein and heat shock protein 70. These results support the hypothesis that C60 induces oxidative stress in this model system.


Asunto(s)
Fulerenos/toxicidad , Regulación de la Expresión Génica/efectos de los fármacos , Estrés Oxidativo/efectos de los fármacos , Acetilcisteína/farmacología , Animales , Butionina Sulfoximina/farmacología , Proteínas Portadoras/efectos de los fármacos , Proteínas Portadoras/metabolismo , Embrión no Mamífero/efectos de los fármacos , Embrión no Mamífero/metabolismo , Ferritinas/efectos de los fármacos , Ferritinas/metabolismo , Glutamato-Cisteína Ligasa/efectos de los fármacos , Glutamato-Cisteína Ligasa/metabolismo , Glutatión Transferasa/efectos de los fármacos , Glutatión Transferasa/metabolismo , Proteínas HSP70 de Choque Térmico/efectos de los fármacos , Proteínas HSP70 de Choque Térmico/metabolismo , Peróxido de Hidrógeno/metabolismo , Luz , Maleatos/farmacología , Análisis por Micromatrices , Modelos Animales , Derrame Pericárdico/inducido químicamente , Factores de Tiempo , Pez Cebra
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA